Maude Cejudo Physical Therapy

02/14/2026

It’s true

A new French-developed technology uses "Focused Ultrasound" (HIFU) to heat and destroy cancer tumors deep inside the body with surgical precision—and zero incisions.

It’s like using a magnifying glass to burn a leaf, but the "leaf" is a prostate or breast tumor. There is no radiation, no hair loss, and no months of debilitating sickness. You walk in, the sound waves "zap" the tumor, and you walk out the same day.

In the US, however, the "Cancer Economy" is built on the recurring revenue of chemotherapy and radiation. Insurance companies are slow to cover "Sound-Wave" therapy because it’s a "one-and-done" procedure that eliminates years of follow-up drug sales.

While French patients are curing their cancer during a lunch break, Americans are still being poisoned by 1970s-era "Chemo-cocktails" because they are more "profitable" for the hospital.

Should "Non-Invasive" cancer cures be mandated as the "First-Line" treatment in the US?

📊 Source: [IFPMA Global Health Architecture, February 2026]

02/07/2026

Read research results

🚨 The Media Calls RFK Jr. "Crazy" on Keto and Schizophrenia—But the Science Says Otherwise

Major outlets such as The New York Times recently described Health Secretary Robert F. Kennedy Jr.'s suggestion that ketogenic or grain-free diets could help, or even "cure," schizophrenia as "unfounded."

Coverage framed it as an extreme claim, with headlines noting that he "vastly overstates preliminary research" and experts labeling it "misleading."

However, a detailed review of more than 75 years of peer-reviewed literature paints a markedly different picture.

Rather than being baseless, RFK Jr.'s comments align with historical epidemiological patterns, double-blind controlled trials, documented cases of full remission, and well-described biological mechanisms—much of which received little to no mention in the critical reporting.

🔍 Key evidence includes:

📄 Historical and Epidemiological Findings

• 1966 – Dohan (American Journal of Clinical Nutrition): During World War II, reduced wheat and rye consumption in five countries was associated with significant declines in first hospital admissions for schizophrenia. Admissions increased again when grain intake returned to pre-war levels.

• 1984 – Dohan et al. (Biological Psychiatry): In traditional grain-free societies (Papua New Guinea, Solomon Islands, Micronesia), chronic schizophrenia was extremely rare, with only 2 cases observed among more than 65,000 people. Rates rose to levels comparable to Western populations after these societies adopted grain-heavy diets.

• 1976 – Singh and Kay (Science): In a double-blind study, wheat gluten challenge in patients maintained on a grain-free and milk-free diet reversed clinical improvements. Symptoms improved when gluten was removed and worsened upon rechallenge.

📊 Modern Clinical Trials and Case Studies

• 2019 – Kelly et al. (Journal of Psychiatry and Neuroscience): Double-blind pilot randomized controlled trial (N=16) in schizophrenia patients with elevated anti-gliadin IgG antibodies. A gluten-free diet led to improvements in psychiatric symptoms, gastrointestinal symptoms, and reduced levels of inflammatory markers (TNF-α, IL-23).

• 2025 – Kelly et al.: Larger double-blind randomized controlled trial (N=39). Gluten-free intervention produced significant reductions in negative symptoms such as anhedonia, avolition, and social withdrawal.

• 2024 – Kim et al. (Schizophrenia Research): Re-analysis of the 2019 pilot data showed that gluten removal decreased oxidative stress, with reductions correlating to improvements in symptoms and inflammation.

• 2017 and 2019 – Palmer et al. (Harvard/McLean Hospital, Schizophrenia Research): Case reports of treatment-resistant schizophrenia and schizoaffective disorder patients achieving complete remission on a ketogenic diet. Symptoms recurred after discontinuing the diet and resolved again upon resumption. Some patients discontinued antipsychotic medications entirely and remained stable long-term (one case symptom-free since 1993).

• 2024 – Sethi et al. (Stanford, Psychiatry Research): 4-month single-arm pilot trial (N=21) in patients with schizophrenia or bipolar disorder and metabolic comorbidities. The schizophrenia subgroup showed approximately 32% reduction in Brief Psychiatric Rating Scale scores, with 79% achieving clinically meaningful improvement. Additional benefits included roughly 12% weight loss, improved metabolic markers, sleep, and quality of life.

🔬Biological Mechanisms

• Anti-gliadin IgG antibodies (present in approximately 25–30% of schizophrenia cases) cross-react with neuronal proteins such as synapsin I.

• Wheat germ agglutinin can cross the blood-brain barrier and promote neuroinflammation.

• Gluten-derived exorphins interfere with opioid receptor signaling in the brain.

• Certain wheat components may contribute to excitotoxicity and metabolic dysfunction in susceptible individuals.

Schizophrenia carries an enormous burden, costing the United States approximately $367 billion annually, with substantially elevated su***de risk and a life expectancy reduced by 15–20 years.

Standard treatments leave many patients, particularly those who are treatment-resistant, with limited options.

Yet dietary interventions with promising evidence have received comparatively little attention or research funding.

Instead of dismissing RFK Jr.'s statements as unfounded, the reporting could have included direct input from leading researchers in the field, such as Chris Palmer (Harvard), Shebani Sethi (Stanford), and Deanna Kelly (University of Maryland).

The evidence is substantial and merits serious, unbiased consideration.

🔗 Read the full article from Sayer Ji here: https://sayerji.substack.com/p/unfounded-rfk-jrs-grain-free-schizophrenia

02/06/2026

I really like this line

02/05/2026

The United Kingdom has made medical history by treating its first multiple sclerosis (MS) patient with innovative CAR T-cell therapy. This advanced treatment involves extracting a patient’s own immune cells, engineering them to target specific components of the immune system, and reintroducing them into the body to combat the disease. MS is an autoimmune condition where the immune system attacks the protective coating of nerve fibers, leading to symptoms such as fatigue, mobility issues, and cognitive challenges.
CAR T-cell therapy is designed to recalibrate the immune system, eliminating harmful immune cells while preserving healthy ones. In early trials, this approach has shown promise in halting disease progression, reducing inflammation, and potentially repairing neurological damage. For the UK patient, the therapy represents hope for improved quality of life and long-term disease control, particularly for individuals who have not responded to conventional treatments.
Experts are closely monitoring outcomes to understand both safety and effectiveness, with the potential for this therapy to revolutionize MS care globally. By targeting the root cause of immune dysfunction, CAR T-cell therapy offers a more precise and personalized approach compared to traditional medications, which often manage symptoms rather than addressing underlying disease mechanisms.
This milestone highlights the growing role of immunotherapy in treating autoimmune disorders, demonstrating how cutting-edge science can transform the lives of patients and reshape the future of medicine.

02/04/2026

This was an American patent that the Japonese have put in toothpaste for 10 yrs, good for gum healing and tooth strength. Best amount 10%

01/28/2026

This is the ingredient I look for in a toothpaste.

01/22/2026

Want skin ti look youthful, decrease scarring

01/16/2026

Israeli focused ultrasound vaporized tumors through intact skin instantly, while US hospitals charge triple abroad

Israeli engineers perfected a system using MRI-guided focused ultrasound beams that converge on tumors with such precision and intensity that cancer tissue literally heats up and vaporizes within minutes—all without cutting skin. Imagine using a magnifying glass to focus sunlight to a burning point, but instead of visible light, it's ultrasound waves converging inside the body. The surrounding tissue stays cool because only the focal point where beams intersect reaches destructive temperatures. Patients walk in with tumors, walk out tumor-free 20 minutes later, no incision, no anesthesia, no recovery period.

The technology works for breast tumors, prostate cancer, liver tumors, uterine fibroids, and bone metastases. Israel has been using this commercially since 2019—over 5,000 procedures performed with 94% complete tumor destruction and virtually zero complications. Patients return to work the same day. No infection risk, no surgical scarring, no weeks of healing. The MRI ensures millimeter precision, protecting nerves and blood vessels.

American hospitals charge $85,000-$120,000 for focused ultrasound procedures, while Israeli clinics charge $28,000-$35,000 for identical treatment using the same equipment. Medical tourism agencies report thousands of Americans traveling to Israel specifically for this procedure. U.S. pricing reflects hospital markups, facility fees, and physician charges that have zero relation to actual treatment costs. Insurance coverage is inconsistent—some plans approve it, others reject it as "not medically necessary" compared to surgery.

Americans face a choice: pay triple for treatment in the U.S., fly to Israel saving $50,000+, or accept invasive surgery with all its risks and recovery time. The technology is no different—only the billing systems change. Why do identical medical procedures cost 3x more on American soil?

📊 Source: Technion Israel Institute of Technology, May 2020

01/13/2026

Wow

Insightec's focused ultrasound just made cancer surgery obsolete for prostate, liver, and bone tumors. No incisions, no anesthesia, no recovery time—just targeted sound waves destroying tumors while patients stay fully awake and walk out 30 minutes later ⚡

The physics is remarkable: Over 1,000 ultrasound beams converge on a tumor from different angles, each beam harmless individually. Where they intersect, the temperature spikes to 85°C (185°F), instantly vaporizing cancer tissue. MRI guidance ensures millimeter precision. The body naturally absorbs dead cells over 2-3 weeks. Patients experience what feels like deep warmth. The entire procedure takes 20 minutes per tumor site. Success rate matches surgical removal without the 6-week recovery, infection risks, or anesthesia complications.

Here's the pricing scandal: Developed in Israel using joint U.S.-Israeli research funding, the treatment costs $12,000 at Sheba Medical Center in Tel Aviv. American hospitals charge $35,000-$45,000 for identical procedures using the same Insightec machines. Why? U.S. hospitals add facility fees, anesthesiologist standby charges (despite not using anesthesia), and "advanced technology surcharges." Insurance companies negotiate rates that keep prices high to justify premium increases. Medical tourism companies now offer Tel Aviv packages—$12,000 treatment + round-trip flight + 4-night hotel stay = still $8,000 cheaper than U.S. treatment alone.

Every year, 268,000 American men get diagnosed with prostate cancer. Most face surgery with 40% erectile dysfunction rates and 15% incontinence. The non-invasive alternative exists, developed partly with their tax dollars, but costs triple domestically while being affordable overseas.

Should Americans pay 300% markups for technology their government helped fund?

📊 Source: Insightec Clinical Data & Sheba Medical Center, August 2025

01/12/2026

Medical tourism , focused US noninvasive prostate Ca, insightech

Insightec's focused ultrasound just made cancer surgery obsolete for prostate, liver, and bone tumors. No incisions, no anesthesia, no recovery time—just targeted sound waves destroying tumors while patients stay fully awake and walk out 30 minutes later ⚡

The physics is remarkable: Over 1,000 ultrasound beams converge on a tumor from different angles, each beam harmless individually. Where they intersect, the temperature spikes to 85°C (185°F), instantly vaporizing cancer tissue. MRI guidance ensures millimeter precision. The body naturally absorbs dead cells over 2-3 weeks. Patients experience what feels like deep warmth. The entire procedure takes 20 minutes per tumor site. Success rate matches surgical removal without the 6-week recovery, infection risks, or anesthesia complications.

Here's the pricing scandal: Developed in Israel using joint U.S.-Israeli research funding, the treatment costs $12,000 at Sheba Medical Center in Tel Aviv. American hospitals charge $35,000-$45,000 for identical procedures using the same Insightec machines. Why? U.S. hospitals add facility fees, anesthesiologist standby charges (despite not using anesthesia), and "advanced technology surcharges." Insurance companies negotiate rates that keep prices high to justify premium increases. Medical tourism companies now offer Tel Aviv packages—$12,000 treatment + round-trip flight + 4-night hotel stay = still $8,000 cheaper than U.S. treatment alone.

Every year, 268,000 American men get diagnosed with prostate cancer. Most face surgery with 40% erectile dysfunction rates and 15% incontinence. The non-invasive alternative exists, developed partly with their tax dollars, but costs triple domestically while being affordable overseas.

Should Americans pay 300% markups for technology their government helped fund?

📊 Source: Insightec Clinical Data & Sheba Medical Center, August 2025